Here are the answers to some of the most common questions regarding West
Nile Virus. All the information has been provided by the Center for Disease
Control.
Q.
What is West Nile Virus?
A. West Nile Virus is a flavivirus commonly found in Africa, West Asia,
and the Middle East. It is closely related to St. Louis encephalitis virus
which is also found in the United States. The virus can infect humans,
birds, mosquitoes, horses and some other mammals
Q.
What are West Nile encephalitis, West Nile meningitis and “neuroinvasive
disease”?
A. The most severe type of disease due to a person being infected with
West Nile virus is sometimes called “neuroinvasive disease”
because it affects a person’s nervous system. Specific types of
neuroinvasive disease include: West Nile encephalitis, West Nile meningitis
or West Nile meningoencephalitis. Encephalitis refers to an inflammation
of the brain, meningitis is an inflammation of the membrane around the
brain and the spinal cord, and meningoencephalitis refers to inflammation
of the brain and the membrane surrounding it.
Q. What are the symptoms of West Nile Virus (WNV) encephalitis?
A. The symptoms include headache, high fever, neck stiffness, stupor,
disorientation, coma, tremors, convulsions, muscle weakness, and paralysis.
It is estimated that approximately 1 in 150 persons infected with the
West Nile virus will develop a more severe form of disease. Serious illness
can occur in people of any age, however people over age 50 and some immunocompromised
persons (for example, transplant patients) are at the highest risk for
getting severely ill when infected with WNV.
Q. What is the incubation period in humans (i.e., time from infection
to onset of disease symptoms) for West Nile disease?
A. Usually 2 to 15 days.
Q. How long do symptoms last?
A. The symptoms of encephalitis or meningitis may last several weeks,
although neurological effects may be permanent.
Q. How is West Nile encephalitis treated?
A. There is no specific treatment for West Nile virus infection. In more
severe cases, intensive supportive therapy is indicated, often involving
hospitalization, intravenous fluids, airway management, respiratory support
(ventilator), prevention of secondary infections (pneumonia, urinary tract,
etc.), and good nursing care.
For more
information, please visit these sites:
The US Center
for Disease Control and Prevention |